Descripción del proyecto
Una plataforma de sanidad electrónica para el diagnóstico y tratamiento de afecciones gastrointestinales
El equipo del proyecto eCAP, financiado con fondos europeos, pretende crear un producto sanitario innovador que combine una cápsula inteligente con una plataforma de sanidad electrónica para emitir diagnósticos, tratar enfermedades y obtener mejores resultados para los pacientes con enfermedades gastrointestinales (GI). El equipo del proyecto creará una cápsula modular implantable con capacidad de multidetección para observar la fisiología GI. Utilizará el estándar de comunicación de los teléfonos inteligentes con la tecnología de computación en nube y las interfaces de las aplicaciones para integrar, procesar e interpretar los datos fisiológicos longitudinales recogidos por la cápsula. Las pruebas personalizadas proporcionarán resultados precisos a partir de la introducción de datos de varios flujos que una inteligencia artificial interpretará. El ambicioso objetivo es favorecer la transición del diagnóstico de afecciones GI hacia un enfoque de sanidad electrónica centrado en el paciente y hacia unos productos sanitarios conectados para monitorizar a los pacientes de forma remota.
Objetivo
eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics, patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our project will create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlled time period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitous smartphone communication standard, together with cloud computing technology and application interfaces to integrate, process and interpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinical usefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the test for the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by Artificial Intelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctors worldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings using gastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluation with health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developed to train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantable capsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue version to a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remote patient monitoring.
Ámbito científico
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesbasic medicinephysiology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health sciencesclinical medicinegastroenterology
Palabras clave
Programa(s)
Régimen de financiación
HORIZON-IA - HORIZON Innovation ActionsCoordinador
67000 Strasbourg
Francia